Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Juan-Jesús Cruz
Phase II Pilot Study of the Prednisone to Dexamethasone Switch in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients With Limited Progression on Abiraterone Plus Prednisone (SWITCH Study)
British Journal of Cancer
Cancer Research
Oncology
Related publications
Germline Variant in SLCO2B1 and Response to Abiraterone Acetate Plus Prednisone (AA) in New Onset Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Molecular Cancer Therapeutics
Cancer Research
Oncology
Pcn40 - A Retrospective Study on Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Prescribed Abiraterone Acetate + Prednisone Prior to Chemotherapy in Sweden, Norway and Denmark
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Phase II Trial of Cisplatin Plus Prednisone in Docetaxel-Refractory Castration-Resistant Prostate Cancer Patients
Cancer Chemotherapy and Pharmacology
Cancer Research
Toxicology
Oncology
Pharmacology
Mp52-11 Association of Dose Reduction of Abiraterone Acetate Plus Prednisone or Enzalutamide and Psa Progression in Veterans With Metastatic Castration Resistant Prostate Cancer
Journal of Urology
Urology
Mp50-20 Impact of Abiraterone Acetate in Prostate Specific Antigen Trial Update: Effect of Abiraterone Acetate and Low Dose Prednisone on Prostate-Specific Antigen and Radiographic Disease Progression in Patients With Non-Metastatic Castration-Resistant Prostate Cancer
Journal of Urology
Urology
Medical Resource Utilization of Abiraterone Acetate Plus Prednisone Added to Androgen Deprivation Therapy in Metastatic Castration-Naive Prostate Cancer: Results From LATITUDE
Cancer
Cancer Research
Oncology
Phase II, Multicenter, Randomized Trial of Docetaxel Plus Prednisone With or Without Cediranib in Men With Chemotherapy‐Naive Metastatic Castrate‐Resistant Prostate Cancer
Oncologist
Cancer Research
Medicine
Oncology
Phase II Randomized Study of Figitumumab Plus Docetaxel and Docetaxel Alone With Crossover for Metastatic Castration-Resistant Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
Influence of Enzalutamide on Cabazitaxel Pharmacokinetics; A Drug-Drug Interaction Study in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients
Clinical Cancer Research
Cancer Research
Oncology
